6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Stunted Growth in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cassens, J; Höbing, L; Hoyer-Kuhn, H; Schoenau, E; Semler, O | 1 |
1 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Stunted Growth
Article | Year |
---|---|
Children with severe Osteogenesis imperfecta and short stature present on average with normal IGF-I and IGFBP-3 levels.
Topics: Adolescent; Bone Density Conservation Agents; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Diphosphonates; Female; Growth Disorders; Hospitals, Pediatric; Hospitals, University; Humans; Infant; Infusions, Intravenous; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Male; Osteogenesis Imperfecta; Outpatient Clinics, Hospital; Retrospective Studies; Severity of Illness Index | 2016 |